UniProt ID | PSN1_HUMAN | |
---|---|---|
UniProt AC | P49768 | |
Protein Name | Presenilin-1 | |
Gene Name | PSEN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 467 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . Cytoplasmic granule . Cell membrane . Translocates with bound NOTCH1 from the endoplasmic reticulum and/or Golgi to the cell surfa |
|
Protein Description | Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein). [PubMed: 15274632] | |
Protein Sequence | MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAKHVIMLFVPVTLCMVVVVATIKSVSFYTRKDGQLIYTPFTEDTETVGQRALHSILNAAIMISVIVVMTILLVVLYKYRCYKVIHAWLIISSLLLLFFFSFIYLGEVFKTYNVAVDYITVALLIWNFGVVGMISIHWKGPLRLQQAYLIMISALMALVFIKYLPEWTAWLILAVISVYDLVAVLCPKGPLRMLVETAQERNETLFPALIYSSTMVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
39 (in isoform 3) | Phosphorylation | - | 43.67 | 25849741 | |
39 (in isoform 2) | Phosphorylation | - | 43.67 | 25849741 | |
43 | Phosphorylation | QEHNDRRSLGHPEPL HHHHCHHCCCCCCCC | 39.33 | 25159151 | |
51 | Phosphorylation | LGHPEPLSNGRPQGN CCCCCCCCCCCCCCC | 48.21 | 25159151 | |
59 | Phosphorylation | NGRPQGNSRQVVEQD CCCCCCCCCCCCCCC | 30.80 | 23927012 | |
74 | Phosphorylation | EEEDEELTLKYGAKH HHHCHHHHHHHCCHH | 25.20 | - | |
76 | Ubiquitination | EDEELTLKYGAKHVI HCHHHHHHHCCHHHH | 36.08 | - | |
77 | Phosphorylation | DEELTLKYGAKHVIM CHHHHHHHCCHHHHH | 25.98 | 26074081 | |
90 | Phosphorylation | IMLFVPVTLCMVVVV HHHHHHHHHHHHHHH | 14.26 | 26074081 | |
99 | Phosphorylation | CMVVVVATIKSVSFY HHHHHHHHHHHCEEE | 19.82 | 26074081 | |
102 | Phosphorylation | VVVATIKSVSFYTRK HHHHHHHHCEEEECC | 21.10 | 26074081 | |
104 | Phosphorylation | VATIKSVSFYTRKDG HHHHHHCEEEECCCC | 21.45 | 26074081 | |
105 (in isoform 2) | Ubiquitination | - | 7.28 | 21906983 | |
105 (in isoform 3) | Ubiquitination | - | 7.28 | 21906983 | |
106 | Phosphorylation | TIKSVSFYTRKDGQL HHHHCEEEECCCCEE | 9.72 | 26074081 | |
107 | Phosphorylation | IKSVSFYTRKDGQLI HHHCEEEECCCCEEE | 29.27 | 26074081 | |
109 (in isoform 6) | Ubiquitination | - | 59.41 | 21906983 | |
109 (in isoform 1) | Ubiquitination | - | 59.41 | 21906983 | |
109 (in isoform 4) | Ubiquitination | - | 59.41 | 21906983 | |
109 (in isoform 5) | Ubiquitination | - | 59.41 | 21906983 | |
109 | Ubiquitination | SVSFYTRKDGQLIYT HCEEEECCCCEEEEE | 59.41 | 21906983 | |
154 | Phosphorylation | TILLVVLYKYRCYKV HHHHHHHHHHHHHHH | 8.38 | - | |
240 | Phosphorylation | MALVFIKYLPEWTAW HHHHHHHHCHHHHHH | 23.75 | - | |
256 | Phosphorylation | ILAVISVYDLVAVLC HHHHHHHHHHHHHHC | 9.21 | - | |
310 (in isoform 2) | Ubiquitination | - | 25.06 | 21906983 | |
310 | Phosphorylation | PEAQRRVSKNSKYNA HHHHHHHCCCCCCCC | 25.06 | 29496963 | |
311 | Ubiquitination | EAQRRVSKNSKYNAE HHHHHHCCCCCCCCC | 63.48 | - | |
313 | Phosphorylation | QRRVSKNSKYNAEST HHHHCCCCCCCCCCC | 40.01 | 29496963 | |
314 | Ubiquitination | RRVSKNSKYNAESTE HHHCCCCCCCCCCCC | 52.50 | 2190698 | |
314 (in isoform 1) | Ubiquitination | - | 52.50 | 21906983 | |
315 | Phosphorylation | RVSKNSKYNAESTER HHCCCCCCCCCCCCC | 21.30 | 30576142 | |
319 | Phosphorylation | NSKYNAESTERESQD CCCCCCCCCCCHHHC | 32.91 | 29255136 | |
320 | Phosphorylation | SKYNAESTERESQDT CCCCCCCCCCHHHCC | 30.48 | 29255136 | |
324 | Phosphorylation | AESTERESQDTVAEN CCCCCCHHHCCCCCC | 39.31 | 25849741 | |
327 | Phosphorylation | TERESQDTVAENDDG CCCHHHCCCCCCCCC | 17.61 | 30576142 | |
337 | Phosphorylation | ENDDGGFSEEWEAQR CCCCCCCCHHHHHHC | 37.57 | 25849741 | |
346 | Phosphorylation | EWEAQRDSHLGPHRS HHHHHCCCCCCCCCC | 23.85 | 23403867 | |
353 (in isoform 3) | Phosphorylation | - | 45.33 | 20068231 | |
353 | Phosphorylation | SHLGPHRSTPESRAA CCCCCCCCCHHHHHH | 45.33 | 23401153 | |
354 | Phosphorylation | HLGPHRSTPESRAAV CCCCCCCCHHHHHHH | 30.91 | 12056836 | |
357 (in isoform 5) | Phosphorylation | - | 28.55 | 20068231 | |
357 | Phosphorylation | PHRSTPESRAAVQEL CCCCCHHHHHHHHHH | 28.55 | 26055452 | |
363 (in isoform 3) | Phosphorylation | - | 43.98 | 20068231 | |
365 | Phosphorylation | RAAVQELSSSILAGE HHHHHHHHHHHHCCC | 22.68 | 29255136 | |
366 | Phosphorylation | AAVQELSSSILAGED HHHHHHHHHHHCCCC | 33.74 | 29255136 | |
367 (in isoform 5) | Phosphorylation | - | 20.46 | 20068231 | |
367 | Phosphorylation | AVQELSSSILAGEDP HHHHHHHHHHCCCCH | 20.46 | 29255136 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
310 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
310 | S | Phosphorylation | Kinase | PRKACA | P00517 | GPS |
310 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
310 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
319 | S | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
320 | T | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
346 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
346 | S | Phosphorylation | Kinase | KPCA | P17252 | PhosphoELM |
346 | S | Phosphorylation | Kinase | PRKCA | P05696 | GPS |
346 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
353 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
354 | T | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
354 | T | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
354 | T | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
354 | T | Phosphorylation | Kinase | DYRK1A | Q61214 | PSP |
357 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
397 | S | Phosphorylation | Kinase | GSK3B | P49841 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:12354302 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF6 | Q9Y4K3 | PMID:23707529 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
346 | S | Phosphorylation |
| 14576165 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSN1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00056 | Alzheimer's disease (AD) | |||||
H00078 | Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia | |||||
H00294 | Dilated cardiomyopathy (DCM) | |||||
H00681 | Acne inversa; Hidradenitis supprativa | |||||
OMIM Disease | ||||||
607822 | Alzheimer disease 3 (AD3) | |||||
600274 | Frontotemporal dementia (FTD) | |||||
613694 | Cardiomyopathy, dilated 1U (CMD1U) | |||||
613737 | Acne inversa, familial, 3 (ACNINV3) | |||||
Kegg Drug | ||||||
D08869 | Begacestat (USAN/INN) | |||||
D09010 | Tarenflurbil (USAN/INN); R-Flurbiprofen | |||||
D09377 | Semagacestat (USAN/INN) | |||||
D09869 | Avagacestat (USAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43; SER-365 AND SER-367,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND MASSSPECTROMETRY. | |
"Phosphorylation of presenilin 1 at the caspase recognition siteregulates its proteolytic processing and the progression ofapoptosis."; Fluhrer R., Friedlein A., Haass C., Walter J.; J. Biol. Chem. 279:1585-1593(2004). Cited for: PHOSPHORYLATION AT SER-310 AND SER-346, AND MUTAGENESIS OF SER-310 ANDSER-346. |